Used in research as a potent and selective inhibitor of Janus kinase 1 (JAK1), showing potential in the development of treatments for autoimmune and inflammatory diseases such as rheumatoid arthritis and psoriasis. Demonstrates high cellular activity and favorable pharmacokinetic properties in preclinical studies, making it a candidate for targeted therapy in immune-mediated conditions. Also utilized in biochemical assays to study JAK-STAT signaling pathways.